Evidence map›Paper›PMID 31160815›Full record

ArticleNature medicine2019

Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer.

Jakob Nikolas Kather, Alexander T Pearson, Niels Halama, Dirk Jäger, Jeremias Krause, Sven H Loosen, Alexander Marx, Peter Boor, Frank Tacke, Ulf Peter Neumann and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Nature medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 703 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
703citing papers in PubMed, 4 pooled it
87.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

703 citing papers in PubMed, 4 syntheses or guidelines pooled it, 1,358 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

643 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 5 countries.

Jakob Nikolas KatherDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany. jkather@ukaachen.de.ORCID http://orcid.org/0000-0002-3730-5348
Alexander T PearsonHematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
Niels HalamaGerman Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0003-0344-6027
Dirk JägerGerman Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Jeremias KrauseDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.ORCID http://orcid.org/0000-0001-9915-7400
Sven H LoosenDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Alexander MarxInstitute of Pathology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
Peter BoorInstitute of Pathology and Department of Nephrology, University Hospital RWTH Aachen, Aachen, Germany.ORCID http://orcid.org/0000-0001-9921-4284
Frank TackeHepatology and Gastroenterology, Charité University Medicine, Berlin, Germany.
Ulf Peter NeumannVisceral and Transplant Surgery, University Hospital RWTH Aachen, Aachen, Germany.
Heike I GrabschPathology & Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0001-9520-6228
Takaki YoshikawaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Hermann BrennerGerman Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Jenny Chang-ClaudeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Michael HoffmeisterDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Christian TrautweinDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Tom LueddeDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany. tluedde@ukaachen.de.ORCID http://orcid.org/0000-0002-6288-8821
German Cancer Research Center · DERWTH Aachen University · DECharité - Universitätsmedizin Berlin · DEHeidelberg University · DEKanagawa Prefectural Hospital Organization · JPUniversität Hamburg · DEUniversitätsklinikum Aachen · DEUniversity of Chicago · USUniversity of Leeds · GB

Funding

A reasoned approach to combination therapy development in head and neck cancerK08DE026500 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PEARSON, ALEXANDER THOMAS · 2016 to 2020
$800k
NIDCR NIH HHS K08 DE026500
6 · The paper itself

Abstract

Microsatellite instability determines whether patients with gastrointestinal cancer respond exceptionally well to immunotherapy. However, in clinical practice, not every patient is tested for MSI, because this requires additional genetic or immunohistochemical tests. Here we show that deep residual learning can predict MSI directly from H&E histology, which is ubiquitously available. This approach has the potential to provide immunotherapy to a much broader subset of patients with gastrointestinal cancer.

Indexed as

Deep LearningMicrosatellite InstabilityGastrointestinal NeoplasmsHumansImmunotherapy

Identifiers

PMID31160815
PMCPMC7423299
OpenAlexW2948930564

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.